Recent MSK Discoveries & Advances

Our Research Impact
Paul Marks Prize for Cancer Research
Recent MSK Discoveries & Advances
Research Awards & Honors
Researcher Interviews
Emeritus Faculty

Recent MSK Discoveries & Advances

Share
Share

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
373 News Items found
In the Lab
Physician-scientist Piro Lito
Why KRAS Inhibitors for Lung Cancer Stop Working (and What Can Be Done about It)

Recently developed targeted drugs used to treat lung cancer are only partially effective. Scientists now know why.
In the News
a design of colored lines and dots
10 Remarkable Basic Science Breakthroughs from 2019

As 2019 comes to an end, take a moment to reflect on the science stories that made the year one to remember.
In the Lab
Enlarged image of neuroblastoma cell with stains.
Neuroblastoma May Result from DNA Circles Wreaking Havoc on the Genome

Mysterious circular DNA may contribute to neuroblastoma and other childhood cancers.
In the News
Memorial Sloan Kettering medical oncologist Eileen O’Reilly
Year in Review: 10 Important Clinical Research Discoveries in 2019

As we approach the end of 2019, learn about some of the biggest advances in clinical research made this year at MSK.
In the Clinic
Illustration of breast cancer cell
Targeted Drug Shows Promise Against HER2-Positive Breast Cancer That Stops Responding to Other Drugs

MSK medical oncologist Shanu Modi is the lead author of a new paper detailing the results from a phase II trial of a breast cancer drug called trastuzumab deruxtecan or DS-8201a. Results from this study were also presented at the San Antonio Breast Cancer Symposium.
Finding
Pedram Razavi, Jorge Reis-Filho, and Bob Li
Many Mutations Detected in Liquid Biopsy Tests Do Not Come from Cancer Cells, an MSK Study Finds

The new findings suggest the need for caution when interpreting the results from these tests.
In the Lab
DLP+ in action
One at a Time: New Tool Can Detect Genetic Changes in Thousands of Single Cancer Cells

Developed by scientists at MSK and the University of British Columbia/BC Cancer, the platform provides the deepest look yet into tumor evolution.
Announcement
Nathanael Gray, Joshua Mendell, and Christopher Vakoc
Three Scientists Are Named Winners of the Paul Marks Prize for Cancer Research

Memorial Sloan Kettering has named three winners of this year’s Paul Marks Prize for Cancer Research, an award that recognizes promising investigators.
In the Lab
a colorful dendritic cell
Newly Discovered Immune Cell Subtypes Could Shake Up Immunotherapy

Dendritic cells, the guards of the immune system, have a previously unrecognized division of labor.
In the Clinic
MSK patient receiving chemotherapy
6 Breakthroughs That Are Changing Chemotherapy for People with Breast Cancer

Discover some of the latest innovations in chemotherapy for breast cancer.